New clinical trials in Latvia: 76 since Nov 2024

Name: New clinical trials in Latvia
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New clinical trials with a site in Latvia: 76 rows for $5, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 2 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/latvia, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 4, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

76 clinical studies with a site in Latvia were first posted on ClinicalTrials.gov from November 12, 2024 to November 4, 2026; 48 have an industry sponsor and 48 are recruiting or about to. The newest, NCT07915219, was posted on November 4, 2026: A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After... (Boehringer Ingelheim).

The request: Every new clinical trial with a site in Latvia, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

76New trials
48Industry sponsored
48Recruiting or not yet
November 4, 2026Latest posted

Newest trials

The newest 76 of 76, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 4, 2026	NCT07915219	A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)	Boehringer Ingelheim	Phase 3	Not yet recruiting	Bronchiectasis	1,500	Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia...	clinicaltrials.gov
October 30, 2026	NCT07908108	Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma...	Istituto Giannina Gaslini	Observational	Active not recruiting	Scleroderma	272	Argentina, Brazil, China, Croatia, Denmark, Egypt, Germany, Greece, India...	clinicaltrials.gov
October 15, 2026	NCT07876232	Comparison of Surgical Techniques for Anterior Shoulder Instability	Riga Stradins University	Not applicable	Recruiting	Surgeons, Shoulder Instability, Bankart Lesions, Bankart Repair, Dynamic Stability	60	Latvia	clinicaltrials.gov
October 13, 2026	NCT07871331	EyeBreathe: A Mixed Reality Game With Eye Tracking and Breathing Biofeedback for Adolescent Basketball Players	Riga Stradins University	Not applicable	Active not recruiting	Healthy Adolescents	45	Latvia	clinicaltrials.gov
October 9, 2026	NCT07869446	Extended Reality Cognitive and Breathing Training With Eye Tracking for Attention and Stress Regulation in Adolescent Basketball Players	Riga Stradins University	Not applicable	Completed	Healthy Adolescents	81	Latvia	clinicaltrials.gov
September 29, 2026	NCT07845487	A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis	Palisade Bio	Phase 2	Recruiting	Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis	204	Canada, Czechia, France, Georgia, Hungary, Italy, Latvia, Poland, Romania...	clinicaltrials.gov
September 18, 2026	NCT07828509	A Retrospective Study on Long-Term Technical Complications of Single Metal-Ceramic Crowns With a Supplementary Questionnaire Survey	Riga Stradins University	Observational	Enrolling by invitation	Metal Ceramic Restorations, Gingival Health	79	Latvia	clinicaltrials.gov
September 11, 2026	NCT07814976	Hyoscine Butylbromide During Transcystic Papillary Balloon Dilation for Choledocholithiasis	Riga East Clinical University Hospital	Not applicable	Recruiting	Choledocholithiasis, Common Bile Duct Stones	50	Latvia	clinicaltrials.gov
July 21, 2026	NCT07716306	Remotely Supervised Exercise During Chemotherapy in Women With Breast Cancer	Riga Stradins University	Not applicable	Not yet recruiting	Breast Cancer	60	Latvia	clinicaltrials.gov
June 16, 2026	NCT07651826	Immiseal™ Dural Sealant Post-Market Registry Study	Medprin Regenerative Medical Technologies Co., Ltd.	Observational	Recruiting	Dural Defect, Cerebrospinal Fluid Leak, Neurosurgical Procedures	85	Latvia	clinicaltrials.gov
June 9, 2026	NCT07634731	Bilateral RSB vs TEA Epidural Analgesia for Postoperative Pain Control After Open Gastrectomy: A Randomized Controlled Trial	Igors Ivanovs	Not applicable	Completed	Bilateral Rectus Sheath Block, Thoracic Epidural Analgesia	60	Latvia	clinicaltrials.gov
May 29, 2026	NCT07614776	A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular...	Amgen	Phase 3	Recruiting	Neovascular Age-related Macular Degeneration, nAMD	304	Czechia, Hungary, Japan, Latvia, Lithuania, Poland, Slovakia, Spain, United...	clinicaltrials.gov
May 28, 2026	NCT07611461	The Effect of Fixed Dentures on Periodontal Tissues in Long-term.	Riga Stradins University	Observational	Enrolling by invitation	Gingival Health, Metal Ceramic Restorations	75	Latvia	clinicaltrials.gov
May 19, 2026	NCT07596849	A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.	argenx	Phase 3	Recruiting	Graves Disease	230	Belgium, Bulgaria, Canada, Denmark, Georgia, Germany, Greece, Italy, Japan...	clinicaltrials.gov
April 8, 2026	NCT07517120	Home-Based Stroke Rehabilitation Using Enriched Environments (PEER-HOMEcare)	Norwegian School of Sport Sciences	Not applicable	Not yet recruiting	Stroke	45	Latvia, Norway, Sweden	clinicaltrials.gov
April 6, 2026	NCT07511686	Metabolic and Mitochondrial Changes in Statin-Induced Myopathy	Riga Stradins University	Observational	Completed	Statin Adverse Reaction, Statin-induced Myopathy	38	Latvia	clinicaltrials.gov
April 2, 2026	NCT07507500	Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months	Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz	Phase 4	Recruiting	Myocardial Infarction (MI)	8,100	Ireland, Latvia, Norway, Poland, Spain	clinicaltrials.gov
March 31, 2026	NCT07503964	The Significance of Laparoscopic Transcystic Papilla Vateri Balloon Dilatation in Patients With Choledocholithiasis.	Riga East Clinical University Hospital	Not applicable	Active not recruiting	Choledocholithiasis, Choledocholithiasis With Cholecystitis	100	Latvia	clinicaltrials.gov
March 24, 2026	NCT07491809	Adhesive Cementation Materials and Techniques in Aesthetic Dentistry	Riga Stradins University	Not applicable	Recruiting	Dental Veneers, Resin Cements, Composite Restoration, Orofacial Esthetic Scale	60	Latvia	clinicaltrials.gov
March 19, 2026	NCT07483827	A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy	eleva GmbH	Phase 1	Recruiting	C3 Glomerulopathy (C3G), Healthy Adult Participants	39	Austria, Belgium, Czechia, France, Greece, Latvia, Lithuania, Netherlands...	clinicaltrials.gov
March 16, 2026	NCT07472517	DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and...	Boehringer Ingelheim	Phase 3	Recruiting	Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC)	670	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
February 27, 2026	NCT07440225	A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)	EyeBiotech Ltd.	Phase 2/3	Recruiting	Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization, Wet Macular Degeneration	960	Argentina, Australia, Estonia, Germany, Israel, Latvia, Poland, Puerto Rico...	clinicaltrials.gov
February 27, 2026	NCT07439458	Tumour Cell Response to Acute Aerobic Exercise in Breast Cancer Survivors: Modulatory Effects of Exercise Type and Intensity	Riga Stradins University	Not applicable	Recruiting	Acute Exercise, Breast Cancer Cell Lines, Breast Cancer Survivors, Healthy Women, Myokine Response	40	Latvia	clinicaltrials.gov
February 20, 2026	NCT07422688	Optical Coherence Tomography in Acute Vessel Evaluation	Aarhus University Hospital Skejby	Not applicable	Enrolling by invitation	Ischemic Heart Disease, Ischemic Coronary Artery Disease, ACS (Acute Coronary Syndrome)	3,000	Belgium, Denmark, Estonia, Finland, Italy, Latvia, New Zealand, Norway, Spain...	clinicaltrials.gov
February 19, 2026	NCT07419802	OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study	Pauls Stradins Clinical University Hospital	Observational	Recruiting	Sepsis, Septic Shock, Blood Purification, Hemoadsorption	29	Latvia	clinicaltrials.gov
February 17, 2026	NCT07415044	LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis	Eli Lilly and Company	Phase 2	Recruiting	Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe	1,431	Argentina, Brazil, Canada, China, Colombia, Croatia, Czechia, France, Greece...	clinicaltrials.gov
February 6, 2026	NCT07393009	BIO\|STREAM.CSP Study	Biotronik SE & Co. KG	Observational	Recruiting	Cardiac Pacing, Cardiac Pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices...	1,000	Australia, Austria, Czechia, France, Germany, Hungary, Israel, Italy, Latvia...	clinicaltrials.gov
January 22, 2026	NCT07360834	Study Aiming to Test Whether Non-invasive Liquid Biopsies Can Safely Reduce Invasive Surveillance Methods in Lynch Syndrome	UNICANCER	Not applicable	Not yet recruiting	Lynch Syndrome	2,000	Croatia, Czechia, Finland, France, Italy, Latvia, Netherlands, Norway, United...	clinicaltrials.gov
January 6, 2026	NCT07318597	Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)	Regeneron Pharmaceuticals	Phase 2	Recruiting	Pulmonary Arterial Hypertension (PAH)	99	Australia, Belgium, France, Germany, Latvia, Poland, South Korea, Spain, United...	clinicaltrials.gov
December 26, 2025	NCT07304921	Novel Approach to Increase EPA and DHA Levels	Riga Stradins University	Phase 1	Completed	Lipid Metabolism, Omega-3 Polyunsaturated Fatty Acids, Supplementation	48	Latvia	clinicaltrials.gov
December 24, 2025	NCT07301736	Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma	Chiesi Farmaceutici S.p.A.	Phase 2	Recruiting	Asthma	780	Argentina, Bosnia and Herzegovina, Bulgaria, Czechia, Germany, Hungary, Latvia...	clinicaltrials.gov
December 16, 2025	NCT07286058	Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis	Takeda	Phase 3	Recruiting	Psoriatic Arthritis	1,182	Australia, China, Croatia, Czechia, Estonia, Germany, Hungary, Israel, Japan...	clinicaltrials.gov
December 16, 2025	NCT07286006	A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)	Immunovant Sciences GmbH	Phase 2	Enrolling by invitation	Graves' Disease	372	Australia, Bulgaria, Czechia, Georgia, Hungary, Israel, Latvia, Poland, South...	clinicaltrials.gov
December 16, 2025	NCT07285655	A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD	Liquidia Technologies, Inc.	Phase 3	Recruiting	Pulmonary Hypertension Due to Lung Disease (Disorder)	344	Australia, Austria, Belgium, Canada, France, Germany, Italy, Latvia, Portugal...	clinicaltrials.gov
December 11, 2025	NCT07276724	A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)	Generate Biomedicines	Phase 3	Recruiting	Severe Asthma	786	Brazil, Bulgaria, Chile, Czechia, Germany, Greece, Hungary, Israel, Latvia...	clinicaltrials.gov
December 9, 2025	NCT07272031	Office Massage Effects on HRV and Stress	Riga Stradins University	Not applicable	Recruiting	Occupational Health, Autonomic Nervous System (ANS) Functioning and Mood State, Stress	140	Latvia	clinicaltrials.gov
December 9, 2025	NCT07271862	A Novel Laparoscopic Apical Promontofixation Technique With Simultaneous Perineal Reconstruction for Patients With Symptomatic Pelvic Organ...	Riga East Clinical University Hospital	Not applicable	Active not recruiting	Pelvic Organ Prolapse (POP), Urinary Incontinence , Stress, Urinary Incontinence (UI), Female Sexual Dysfunction (FSD)...	60	Latvia	clinicaltrials.gov
December 2, 2025	NCT07258290	Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions	Teleflex	Not applicable	Recruiting	Coronary Disease, Heart Diseases, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Vascular...	1,859	Latvia, United States	clinicaltrials.gov
November 28, 2025	NCT07254117	The Role of Granulation Tissue in Periodontal Regeneration	Riga Stradins University	Observational	Completed	Periodontal Bone Loss, Periodontitis, Periodontal Disease, Periodontal Diseases, Periodontal Regeneration, Periodontal...	34	Latvia	clinicaltrials.gov
November 19, 2025	NCT07235462	A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a...	Bayer	Observational	Recruiting	Transthyretin Amyloid Cardiomyopathy (ATTR-CM)	2,000	Austria, Belgium, Croatia, Denmark, Estonia, Finland, Germany, Italy, Latvia...	clinicaltrials.gov
November 6, 2025	NCT07225504	A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis	Novartis Pharmaceuticals	Phase 3	Recruiting	Secondary Progressive Multiple Sclerosis (SPMS)	1,275	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China...	clinicaltrials.gov
October 24, 2025	NCT07220915	Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections	Octapharma	Phase 3	Recruiting	Hypogammaglobulinemia, Autoimmune Conditions, Rheumatic Conditions, Infections	360	Bulgaria, Czechia, Greece, Latvia, Lithuania, Poland, United States	clinicaltrials.gov
September 30, 2025	NCT07199439	Post-market Clinical Follow-up Plan of StypCel™ Absorbable Hemostat	Medprin Regenerative Medical Technologies Co., Ltd.	Observational	Completed	Neurosurgery	108	Latvia	clinicaltrials.gov
September 24, 2025	NCT07190209	Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic...	Sanofi	Phase 3	Recruiting	Chronic Obstructive Pulmonary Disease	942	Argentina, Belgium, Brazil, Canada, Chile, China, Denmark, Estonia, Finland...	clinicaltrials.gov
September 16, 2025	NCT07175038	A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung...	AllRock Bio, Inc.	Phase 2	Recruiting	Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease	40	Australia, Canada, France, Germany, Italy, Latvia, Poland, Spain, United States	clinicaltrials.gov
August 24, 2025	NCT07140172	Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront...	University Hospital, Basel, Switzerland	Not applicable	Recruiting	Breast Cancer	1,060	Austria, Canada, Croatia, Germany, Greece, Ireland, Italy, Latvia, Switzerland...	clinicaltrials.gov
August 22, 2025	NCT07136467	A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis...	AbbVie	Observational	Recruiting	Non-Segmental Vitiligo (NSV), Alopecia Areata, Hidradenitis Suppurativa	2,795	Argentina, Canada, Colombia, Czechia, Estonia, France, Germany, Greece, Italy...	clinicaltrials.gov
August 14, 2025	NCT07122180	Post-Market Clinical Follow-Up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy...	MDCECRO LLC	Observational	Enrolling by invitation	Diabetes Mellitus	72	Latvia	clinicaltrials.gov
July 29, 2025	NCT07091682	Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions	Biotronik AG	Not applicable	Active not recruiting	Coronary Artery Disease, Atherosclerosis of Coronary Artery, Myocardial Ischemia, Ischemic Heart Disease, Acute...	100	Germany, Hungary, Italy, Latvia, Poland, Spain, Switzerland	clinicaltrials.gov
July 15, 2025	NCT07064759	Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration	4D Molecular Therapeutics	Phase 3	Recruiting	Neovascular Age-Related Macular Degeneration (nAMD)	480	Argentina, Australia, Bulgaria, France, Germany, Hungary, Israel, Italy, Japan...	clinicaltrials.gov
July 14, 2025	NCT07064473	EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood...	Boehringer Ingelheim	Phase 3	Recruiting	Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases	11,800	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
June 12, 2025	NCT07018323	A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease	Immunovant Sciences GmbH	Phase 2	Recruiting	Graves' Disease	210	Australia, Brazil, Bulgaria, Chile, Czechia, Georgia, Greece, Israel, Italy...	clinicaltrials.gov
June 11, 2025	NCT07015905	REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults	Regeneron Pharmaceuticals	Phase 3	Recruiting	Venous Thromboembolism (VTE)	2,000	Bulgaria, Hungary, Japan, Latvia, Lithuania, Poland, Romania, United States	clinicaltrials.gov
May 25, 2025	NCT06990867	Optimizing Reperfusion to Improve Outcomes and Neurologic Function	Corxel Pharmaceuticals	Phase 2/3	Recruiting	Acute Ischemic Stroke	740	Belgium, Bulgaria, Canada, China, France, Germany, Greece, Hungary, Italy...	clinicaltrials.gov
May 20, 2025	NCT06981078	A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD	Upstream Bio Inc.	Phase 2	Active not recruiting	Chronic Obstructive Pulmonary Disease	666	Argentina, Bulgaria, Chile, Czechia, Georgia, Germany, Hungary, India, Ireland...	clinicaltrials.gov
May 15, 2025	NCT06973291	A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis	Takeda	Phase 3	Completed	Plaque Psoriasis	606	Bulgaria, Canada, Czechia, France, Japan, Latvia, Poland, United States	clinicaltrials.gov
May 11, 2025	NCT06966401	Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive...	Neurocrine Biosciences	Phase 3	Recruiting	Major Depressive Disorder	850	Australia, Belgium, Bulgaria, Canada, Croatia, Czechia, Estonia, Finland...	clinicaltrials.gov
May 8, 2025	NCT06963021	NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major...	Neurocrine Biosciences	Phase 3	Recruiting	Major Depressive Disorder	200	Belgium, Canada, Finland, Hungary, Latvia, United Kingdom, United States	clinicaltrials.gov
May 7, 2025	NCT06961214	Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation...	GlaxoSmithKline	Phase 3	Recruiting	Pulmonary Disease, Chronic Obstructive	961	Argentina, Australia, Austria, Bulgaria, Czechia, Germany, Greece, Israel...	clinicaltrials.gov
May 6, 2025	NCT06959329	Influence of Sensory Stimulation on Sensory Parameters and Motor Function in Children With Developmental Coordination Disorder	The Jerzy Kukuczka Academy of Physical Education in Katowice	Not applicable	Not yet recruiting	Developmental Coordination Disorder	80	Latvia, Poland	clinicaltrials.gov
April 16, 2025	NCT06930625	A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs	Debiopharm International SA	Phase 3	Recruiting	Acromegaly	119	Austria, Belgium, Brazil, Bulgaria, Denmark, Estonia, France, Germany, Hungary...	clinicaltrials.gov
April 10, 2025	NCT06920771	A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL...	HAL Allergy	Phase 3	Completed	House Dust Mite Allergy, House Dust Mite Rhinitis	691	Bulgaria, Germany, Latvia, Lithuania, Poland	clinicaltrials.gov
April 3, 2025	NCT06908226	A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)	Longboard Pharmaceuticals	Phase 3	Enrolling by invitation	Developmental and Epileptic Encephalopathy	324	Australia, Belgium, Brazil, Canada, China, France, Germany, Italy, Japan...	clinicaltrials.gov
March 18, 2025	NCT06880770	Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis	Arrowhead Pharmaceuticals	Phase 3	Recruiting	Severe Hypertriglyceridemia	288	Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, China, Colombia...	clinicaltrials.gov
March 18, 2025	NCT06880744	A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab...	AbbVie	Phase 3	Active not recruiting	Ulcerative Colitis	573	Austria, Bulgaria, Canada, China, Croatia, Czechia, Estonia, Finland, France...	clinicaltrials.gov
March 12, 2025	NCT06872892	The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis	Boehringer Ingelheim	Phase 3	Recruiting	Bronchiectasis	1,755	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
March 5, 2025	NCT06858579	A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)	Dianthus Therapeutics	Phase 3	Recruiting	Chronic Inflammatory Demyelinating Polyneuropathy	256	Argentina, Australia, Belgium, Brazil, Bulgaria, China, Colombia, Croatia...	clinicaltrials.gov
February 26, 2025	NCT06846541	Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis	Alumis Inc	Phase 3	Active not recruiting	Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis, Severe Psoriasis	1,680	Australia, Bulgaria, Canada, Czechia, Estonia, France, Germany, Hungary, Japan...	clinicaltrials.gov
February 25, 2025	NCT06846138	Enhancing the Efficacy and Tolerability of Metformin by add-on Polyherbal Formulation: a Gut Microbiome Study	Pauls Stradins Clinical University Hospital	Not applicable	Enrolling by invitation	Diabetes Mellitus Type 2	66	Latvia	clinicaltrials.gov
February 12, 2025	NCT06822790	Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia	Arrowhead Pharmaceuticals	Phase 3	Active not recruiting	Hypertriglyceridemia	710	Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Croatia...	clinicaltrials.gov
January 14, 2025	NCT06774131	A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer	UroGen Pharma Ltd.	Phase 3	Recruiting	Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma	70	Bulgaria, Georgia, Hungary, Israel, Latvia, Poland, Romania, Spain, United...	clinicaltrials.gov
December 19, 2024	NCT06742190	A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy	argenx	Phase 3	Active not recruiting	Multifocal Motor Neuropathy (MMN), MMN	154	Australia, Austria, Belgium, Brazil, Canada, China, Czechia, Denmark, France...	clinicaltrials.gov
December 16, 2024	NCT06734962	Evaluation of Bone Regeneration After Apical Surgery Using Advanced Platelet-rich Fibrin: Utilization of Ultrasound for the Assessment of...	Riga Stradins University	Phase 2	Active not recruiting	Periapical Lesions	44	Latvia	clinicaltrials.gov
December 10, 2024	NCT06726265	Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and...	Immutep S.A.S.	Phase 3	Active not recruiting	Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)	756	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile...	clinicaltrials.gov
December 5, 2024	NCT06719141	A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)	Longboard Pharmaceuticals	Phase 3	Active not recruiting	Developmental and Epileptic Encephalopathy	367	Australia, Belgium, Brazil, Canada, China, France, Germany, Italy, Japan...	clinicaltrials.gov
November 12, 2024	NCT06684769	A Chitosan Brush and Enamel Matrix Derivative for Non-surgical Treatment of Furcations	Riga Stradins University	Not applicable	Recruiting	Periodontitis, Adult, Furcation Defects, Furcation of Root of Tooth, Periodontitis Complex	40	Latvia	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Riga Stradins University	14	October 15, 2026
Boehringer Ingelheim	4	November 4, 2026
Riga East Clinical University Hospital	3	September 11, 2026
Medprin Regenerative Medical Technologies Co., Ltd.	2	June 16, 2026
argenx	2	May 19, 2026
Pauls Stradins Clinical University Hospital	2	February 19, 2026
Regeneron Pharmaceuticals	2	January 6, 2026
Takeda	2	December 16, 2025
Immunovant Sciences GmbH	2	December 16, 2025
AbbVie	2	August 22, 2025
Neurocrine Biosciences	2	May 11, 2025
Longboard Pharmaceuticals	2	April 3, 2025
Arrowhead Pharmaceuticals	2	March 18, 2025
Istituto Giannina Gaslini	1	October 30, 2026
Palisade Bio	1	September 29, 2026
Igors Ivanovs	1	June 9, 2026
Amgen	1	May 29, 2026
Norwegian School of Sport Sciences	1	April 8, 2026
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz	1	April 2, 2026
eleva GmbH	1	March 19, 2026

Conditions

Condition group	New trials	Latest
Acute Coronary Syndrome	4	April 2, 2026
Colitis, Ulcerative	3	September 29, 2026
Graves Disease	3	May 19, 2026
Myocardial Ischemia	3	February 20, 2026
Hypertension, Pulmonary	3	January 6, 2026
Pulmonary Disease, Chronic Obstructive	3	September 24, 2025
Bronchiectasis	2	November 4, 2026
Choledocholithiasis	2	September 11, 2026
Breast Neoplasms	2	July 21, 2026
Hemorrhage	2	April 2, 2026
Macular Degeneration	2	February 27, 2026
Wet Macular Degeneration	2	February 27, 2026
Heart Failure	2	February 6, 2026
Pulmonary Arterial Hypertension	2	January 6, 2026
Asthma	2	December 24, 2025
Lung Diseases, Interstitial	2	December 16, 2025
Cardiovascular Diseases	2	December 2, 2025
Coronary Artery Disease	2	December 2, 2025
Angina Pectoris	2	December 2, 2025
Diabetes Mellitus	2	August 14, 2025
Diabetes Mellitus, Type 2	2	July 14, 2025
Depressive Disorder, Major	2	May 11, 2025
Depression	2	May 11, 2025
Seizures	2	April 3, 2025
Epilepsy	2	April 3, 2025

By phase

Phase	New trials	Latest
Phase 3	30	November 4, 2026
Not applicable	20	October 15, 2026
Observational	12	October 30, 2026
Phase 2	9	September 29, 2026
Phase 1	2	March 19, 2026
Phase 2/3	2	February 27, 2026
Phase 4	1	April 2, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.